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Objective: Ammonia detoxification is essential for physiological well-being, and the urea cycle in liver plays a
predominant role in ammonia disposal. Nobiletin (NOB), a natural dietary flavonoid, is known to exhibit various
physiological efficacies. In the current study, we investigated a potential role of NOB in ammonia control and the
underlying cellular mechanism.
Materials/methods: C57BL/6 mice were fed with regular chow (RC), high-fat (HFD) or high-protein diet (HPD) and
treated with either vehicle or NOB. Serum and/or urine levels of ammonia and urea were measured. Liver expression of
genes encoding urea cycle enzymes and C/EBP transcription factors was determined over the circadian cycle. Luciferase
reporter assays were carried out to investigate function of CCAAT consensus elements on the carbamoyl phosphate
synthetase (Cps1) gene promoter. A circadian clock-deficient mouse mutant, ClockΔ19/Δ19, was utilized to examine a
requisite role of the circadian clock in mediating NOB induction of Cps1.
Results: NOB was able to lower serum ammonia levels in mice fed with RC, HFD or HPD. Compared with RC, HFD
repressed the mRNA and protein expression of Cps1, encoding the rate-limiting enzyme of the urea cycle. Interestingly,
NOB rescued CPS1 protein levels under the HFD condition via induction of the transcription factors C/EBPα and C/EBPβ.
Expression of other urea cycle genes was also decreased by HFD relative to RC and again restored by NOB to varying
degrees, which, in conjunction with Cps1 promoter reporter analysis, suggested a C/EBP-dependent mechanism for the
co-induction of urea cycle genes by NOB. In comparison, HPD markedly increased CPS1 levels relative to RC, yet NOB
did not further enrich CPS1 to a significant extent. Using the circadian mouse mutant ClockΔ19/Δ19, we also showed that
a functional circadian clock, known to modulate C/EBP and CPS1 expression, was required for NOB induction of CPS1
under the HFD condition.
Conclusion: NOB, a dietary flavonoid, exhibits a broad activity in ammonia control across varying diets, and regulates
urea cycle function via C/EBP-and clock-dependent regulatory mechanisms.
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Ammonia detoxification is an essential bodily function
required for nitrogen homeostasis and physiological
well-being [1–3]. Ammonia molecules are produced
mainly through catabolism of amino acid and other ni-
trogenous metabolites in tissues, and also via amino acid
deamination and urea salvage by gut bacteria [1, 4].
Whereas a small portion of ammonia is removed via dir-
ect renal excretion, the urea cycle in the liver plays a
predominant role in ammonia disposal, converting am-
monia to the relatively harmless urea for excretion [5, 6].
The urea cycle consists of five enzymatic reactions se-
quentially taking place in the mitochondrial matrix and
the cytoplasm of periportal hepatocytes [7, 8]. Carba-
moyl phosphate synthetase 1 (CPS1) catalyzes the first
reaction wherein ammonia and bicarbonate combine to
form carbamoyl phosphate, and mice deficient in Cps1
suffered pronounced hyperammonemia and neonatal le-
thality [9]. As a strikingly abundant protein comprising
as much as 20 % of total mitochondrial matrix protein
mass [10], CPS1 is also subjected to diverse molecular
and cellular regulation. Besides the classically known
allosteric activator N-acetylglutamate (NAG), CPS1 level
and activity are also regulated by complex molecular and
physiological mechanisms [7, 11–16]. Furthermore, co-
ordinate induction of urea cycle components has also
been reported at transcriptional and post-transcriptional
levels [7, 17].
An emerging cellular mechanism for nitrogen homeo-
stasis is our intrinsic biological timer, the circadian clock
[18, 19]. In mammals, core clock genes form interlocked
feedback loops, driving gene expression to regulate vari-
ous metabolic pathways [20–22]. Several earlier studies
have implicated a role of the clock in protein or nitrogen
metabolism [23–25]. More recently, it was shown that
the transcription factor Klf15 is encoded by a clock-
controlled gene, and that Klf15 maintains nitrogen bal-
ance via regulation of the second urea cycle gene Otc
[19]. Furthermore, genomic and proteomic studies have
also demonstrated circadian variation of Cps1 mRNA
and protein expression in mouse liver, although discrep-
ancies remain concerning mRNA oscillation and protein
peaks [26–29].
Apart from the clock being an intrinsic regulator, diet
is an external factor that profoundly influences nitrogen
homeostasis and ammonia metabolism. Dietary manage-
ment for genetic hyperammonemia, mainly including
protein restriction and supplementation of urea cycle
substrate, serves to attenuate ammonia generation and/
or bolster ammonia disposal [3, 30–32]. On the other
hand, dietary challenges also strongly influence ammonia
metabolism and detoxification. For example, the urea-
genic capacity of the urea cycle, while far exceeding de-
mand under normal conditions [14], has been shown tobe up-regulated in response to greater metabolic chal-
lenge [7, 33]. However, ammonia control under varying
diet conditions is not well characterized, and little is
known regarding functional dietary components for am-
monia control besides metabolic substrates [30, 34].
Here, we report novel ammonia-lowering activities and
clock-dependent mechanism for urea cycle regulation of
a natural polyphenolic flavonoid, Nobiletin (NOB).
Materials and methods
Animals
All animal husbandry and experimental procedures were
carried out in accordance with approved IACUC guide-
lines and animal protocols by the University of Texas
Health Science Center at Houston (UTHealth). All mice,
male and on the C57BL/6 background, were group-
housed with 2–4 animals/cage under 12:12 light/dark
(12:12 LD) cycles or constant darkness (DD) when indi-
cated. The point of light-on is considered as Zeitgeber
Time (ZT) 0, whereas the onset of subjective day during
DD is considered as Circadian Time (CT) 0. Animals
were ad libitum fed with regular chow (RC; LabDiet
5001), high-fat diet (HFD; Research Diets D12492) or
high-protein diet (HPD; Research Diets D04080301).
Nobiletin was obtained from commercial sources includ-
ing Sigma and Selleck, and administered via oral gavage
(200 mg/kg in 0.5 % Sodium carboxymethyl cellulose)
every other day.
Ammonia and urea assays
Blood and urine samples were collected at ZT6 and
ZT18. For determination of serum ammonia and urea
concentrations, we employed assay kits (Sigma, AA0100
and MAK006, respectively) according to the manufac-
turer’s protocols.
Plasmids
The proximal Cps1 enhancer [16] was cloned into pGL3
Basic (Promega) using C57BL6/J mouse genomic DNA
as PCR template with pF and pR primers (Additional file 1:
Table S1). Site-directed PCR mutagenesis was performed
to introduce mutations on the C/EBP binding site using
P-C/EBPmutF and P-C/EBPmutR primers (Additional
file 1: Table S1). Likewise, the distal enhancer [35] was
cloned into pGL3 Basic using dF and dR primers. Three
C/EBP binding sites in the distal enhancer region were
incorporated by DNA synthesis (GeneScript). C/EBPα ex-
pression vector was purchased from Addgene (ID12550).
Luciferase reporter assays
For the luminescence assay, Hepa1-6 cells (ATCC, CRL-
1830) were plated the day before transfection at 2 × 104
cells per well in 96-well plates. Cells were transfected
with the indicated vectors with Renilla luciferase vector
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media was changed to recording media as previously de-
scribed [36] and treated with different concentrations of
Nobiletin. Sealed cultures were placed in an EnVision mi-
croplate reader (Perkin Elmer) and bioluminescence from
the tissue was recorded.
Real-time qPCR and Western blot analyses
Total RNAs purified by using Trizol were used for
cDNA synthesis and real-time qPCR was performed with
an Agilent MaxPro3000 Thermocycler using SyBR green
reaction mix (GenDEPOT). The qPCR primers used are
listed in Additional file 1: Table S2.
Tissue collection and Western blotting was performed
as described previously [37, 38]. Briefly, liver tissue sam-
ples were dissected from the same lobular regions in dif-
ferent animals to ensure experimental consistency. The
samples were immediately frozen in liquid nitrogen and
stored at −80 °C prior to use. The harvested liver tissues
were homogenized in extraction buffer containing 0.1 %
TritonX-100. Protein samples were separated by 12 or
6 % SDS-polyacrylamide gel then transferred to a nitro-
cellulose membrane. Anti-CPS1 (Abcam), anti-C/EBPα
(Cell Signaling), anti-C/EBPβ (Abcam) antibodies were
used. Quantitation of Western blot results was carried
out by using ImageJ software (NIH).
Immunohistochemistry
Liver tissues (right lateral lobe) were collected at the in-
dicated times and immediately fixed in 10 % buffered
formalin. For immunohistochemistry, 20-μm sections
were collected using a VibroSlice microtome (World
Precision Instruments) and processed free floating.
Sections were incubated with rabbit anti-CPS1 (1:10,000;
Abcam), followed by Alexa Fluor 546 rabbit secondary
antibody (1:1000; Invitrogen). After 30 min of DAPI stain-
ing (5 μM), Vectashield mounting media (Vector Labs)
was used to mount the liver slices. Section images were
acquired and analyzed by using a Nikon A1R confocal
microscope.
SDS-PAGE and mass spectrometry
Liver extracts were separated on SDS-PAGE gels and
minimally stained with Coomassie blue. The MW
164KD band was excised and digested with trypsin. The
sample was subjected to mass spectrometry protein ID
at the BCM Proteome Core Facility using a Velos-
Orbitrap mass spectrometer. Spectral data were then
identified by using Proteome Discoverer Suites with
Mascot (Orbitrap data) software [39].
Statistical analysis
Unless otherwise stated, results are presented as mean ±
SEM. Data were analyzed using Student’s t-test, one-wayANOVA followed by post-hoc analysis using Dunnett’s
multiple comparison tests or two-way ANOVA followed
by post-hoc analysis using Bonferroni test as appropriate.
A value of p < 0.05 was considered statistically significant.
Results
NOB improves ammonium detoxification
Among a growing number of bioactive polyphenols,
Nobiletin (NOB) is a citrus-derived dietary flavonoid
with diverse physiological functions [40–43]. More re-
cently, NOB has been shown to display a protective role
against high-fat diet (HFD)-induced obesity and other
metabolic dysfunctions [44–46]. To investigate a poten-
tial role of NOB in nitrogen homeostasis, we examined
serum ammonium levels in wild-type (WT) mice under
different diets. Under RC, NOB did not significantly
affect body weight (Fig. 1a). Consistent with previous
findings [44, 45], NOB ameliorated body weight gain
under HFD (Fig. 1a). Importantly however, under both
diets, NOB markedly reduced serum ammonium levels
(Fig. 1b). At Zeitgeber Time (ZT) 6 corresponding to
mid-day (inactive phase), NOB led to a more pro-
nounced reduction for HFD than RC (27.5 % vs 14.4 %)
(Fig. 1b, left). Ammonia-lowering activities of NOB were
also observed at ZT18 corresponding to mid-night when
mice were active (Fig. 1b, right). Whereas attenuated
serum ammonia levels were observed in HFD.Veh than
RC.Veh, likely due to lower protein content in HFD than
RC (20 % vs. 29 % in calories), NOB treatment dimin-
ished the ammonia levels in both diets by similar
degrees.
We next investigated effects of NOB under high-
protein diet (HPD), corresponding to enhanced protein
metabolism and ammonia flux [19]. NOB did not signifi-
cantly affect body weight in these mice (Fig. 1c). At ZT6,
serum ammonia levels were similar between RC and
HPD, and NOB showed a modest trend of reducing
serum ammonia levels (Fig. 1d, left). Importantly, during
the active phase at ZT18 when serum ammonia levels
were significantly elevated in HPD, NOB robustly re-
duced serum ammonia to RC levels (Fig. 1d, right). To-
gether, these results indicated a broad role of NOB in
reducing serum ammonia content at both active and in-
active circadian phases under RC, HFD and HPD condi-
tions. Furthermore, NOB more strongly reduced serum
ammonia levels under HFD and HPD at ZT6 and ZT18
respectively, serving to normalize the exaggerated circa-
dian variation between active and inactive phases in
these diets compared with RC.
Diet-specific effects of NOB on CPS1 expression
Carbamoyl phosphate synthetase I (CPS1) has been
shown to accumulate in a circadian manner; however,































































































































































Fig. 1 Nobiletin (NOB) lowers serum ammonia levels. a Body weight change of wild-type (WT) mice fed with regular chow (RC) or high-fat diet
(HFD) and treated with either vehicle (Veh) or Nobiletin (NOB) for 10 weeks (n = 11–12). ***p < 0.001. b Serum ammonia levels at Zeitgeber Time
(ZT) 6 and 18 in the mice described in (a). ZT0 corresponds to the onset of light phase. c Body weight change of WT mice fed with RC or high-
protein diet (HPD) and treated with either Veh or NOB for 4 weeks (n = 6–7). d Serum ammonia levels at ZT6 and ZT18 in the mice described in
(c). Data are presented as mean ± SEM. For panels b and d, Student’s t-test: Veh vs. NOB, **p < 0.01, ***p < 0.001; RC vs. HFD or HPD, ††p < 0.01
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ducted Western blotting to examine CPS1 protein levels
in mouse liver over circadian time course. While largely
unchanged between Veh and NOB treatment under RC
conditions based on 2-way ANOVA, CPS1 levels were
significantly reduced in HFD.Veh compared with RC
(Fig. 2a and Additional file 1: Figure S1A) [47]. Strik-
ingly, NOB restored CPS1 in HFD to RC levels (Fig. 2a).
We also confirmed the above results using Coomassie
staining followed by mass spectrometry (Additional file
1: Figure S1B and Table S3). Furthermore, confocal mi-
croscopy using anti-CPS1 antibody also clearly showed
recovered CPS1 in livers from HFD.NOB mice relative
to HFD.Veh (Fig. 2b and Additional file 1: Figure S1C).
Real-time qPCR analysis further revealed strong repres-
sion of Cps1 messenger levels by HFD relative to RC
(Fig. 2c), consistent with its effect on CPS1 proteins. Im-
portantly, NOB restored Cps1 mRNA expression, mir-
roring the changes in CPS1 protein.
We also examined effects of HPD on CPS1 levels.
HPD enhanced the abundance of CPS1 by approximately
20 % (Fig. 2d), suggesting a role of CPS1 induction to
cope with increased dietary protein intake. HPD feeding
exerted similar modest inducing effects on Cps1 mRNA
compared with RC (Fig. 2e). NOB treatment, on theother hand, did not further increase CPS1 protein level
under HPD (Fig. 2d), yet seemed to alter the mRNA ex-
pression with a slight increase at ZT18 (Fig. 2e). These
results indicated opposing effects of HFD and HPD on
Cps1 expression, suggesting that ammonia-lowering
activities of NOB entail diet-specific CPS1 regulatory
mechanisms.NOB restored levels of C/EBP transcription factors
repressed under HFD
We next focused on HFD where the above results indi-
cated NOB-mediated transcriptional induction of Cps1.
The transcription factors C/EBPα and C/EBPβ are
known to play important roles in energy homeostasis
and urea cycle expression [7, 48, 49]. Consistent with
previous results [50], liver expression of both Cebp genes
exhibited clear circadian oscillation in RC; somewhat
surprisingly, NOB moderately elevated Cebpa expres-
sion, yet strongly repressed Cebpb (Fig. 3a). HFD signifi-
cantly dampened levels and circadian amplitude (peak/
trough difference) of both Cebp mRNA expression, and
interestingly also reversed their circadian phase. NOB
treatment largely restored Cebpa mRNA expression
(ZT14) and circadian phase relative to RC (Fig. 3a).
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Fig. 2 NOB modulates Cps1 mRNA and protein expression. a Total protein extracts were prepared from liver samples collected from the four
diet/treatment groups of wild-type mice at the indicated circadian time points (n = 3). Western blotting analysis was performed using anti-CPS1
antibody. RC regular chow, HFD high-fat diet, Veh vehicle, NOB Nobiletin. The results shown are representative of three independent experiments.
See Additional file 1: Figure S1A for quantitative analysis. b Immunohistochemical staining of CPS1 in liver sections from mice with the indicated
diet and treatment at ZT2. c Real-time RT-PCR analysis of Cps1 in liver samples collected as in (a). Data are presented as mean ± SEM (n = 3).
Two-way ANOVA with Bonferroni post-hoc tests shows significant statistical differences between HFD.Veh and other three groups (p < 0.0001).
d Western blotting analysis of protein lysates of liver samples collected at ZT 6 and 18 from mice with the indicated diet and treatment (n = 3).
HPD indicates high-protein diet. The images shown to the left are representative of three independent experiments. Quantitation of Western blots
was carried out and the results, presented as mean ± SEM, are shown in the lower panel. Two-way ANOVA with Bonferroni post-hoc tests, RC vs.
HPD, ***p < 0.001. e Real-time qPCR analysis was carried out using total RNAs extracted from the liver samples described in (d). The results are
presented as mean ± SEM. Two-way ANOVA with Bonferroni post-hoc tests, RC vs. HPD, *p < 0.05
Nohara et al. Nutrition & Metabolism  (2015) 12:23 Page 5 of 12HFD also significantly down-regulated protein levels of
C/EBPα p42, the active form [51], across the circadian
cycle (HFD.Veh vs. RC.Veh; Fig. 3b and Additional file 1:
Figure S2A). In comparison, the amount of p30, the trun-
cated form lacking the N-terminal transactivation domain,was also reduced, albeit to a lesser degree (Fig. 3b and
Additional file 1: Figure S2B). Compared with Veh, NOB
did not show significant effects on p42/p30 levels in RC,
yet appeared to reverse their reduction by HFD to RC
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Fig. 3 NOB rescued Cebpa and Cebpb mRNA and protein circadian expression in the liver from HFD fed mice. a Real-time RT-PCR analysis of
Cebpa and Cebpb in livers collected at the indicated circadian times from mice with the indicated diet and treatment as in Fig. 2a. Student’s t-test:
RC.Veh vs. HFD.Veh, *p < 0.05; HFD.Veh vs. HFD.NOB, †p < 0.05. b Western blotting was performed using total liver protein lysates with the indicated
antibodies. The results are representative of three independent experiments. See Additional file 1: Figure S2 for quantitative analysis
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levels in mouse liver [52]. In comparison, our circadian
analysis revealed a C/EBPβ (LAP) phase shift in HFD
(Fig. 3b and Additional file 1: Figure S2C). Whereas
both RC.Veh and RC.NOB showed peak C/EBPβ ex-
pression at ZT20, HFD shifted the peak to ZT14, with
HFD.NOB displaying a slight increase over HFD.Veh
(Fig. 3b and Additional file 1: Figure S2C). These re-
sults illustrated circadian- and diet-dependent expres-
sion patterns of C/EBPs and a novel function of NOB
in restoring C/EBP levels repressed by HFD.C/EBP site mutations on the Cps1 promoter abolished
NOB effects
Previous studies have identified both proximal and distal
C/EBP sites in the Cps1 promoter [16, 35, 53]. We next
generated reporter constructs containing either the in-
tact Cps1 promoter or mutant promoters respectively
deficient in either C/EBP sites (Fig. 4a). NOB was found
to dose-dependently activate reporter expression from
the WT construct with an intact promoter (Fig. 4b and c).
Distal mutations markedly repressed the reporter expres-
sion, yet seemed to at least partially retain NOB responseas NOB increased mutant reporter expression relative to
DMSO (Fig. 4b). In comparison, while not significantly af-
fecting the baseline expression level, proximal mutations
abolished NOB dose-dependent induction seen in the WT
construct (Fig. 4c). C/EBPα co-transfection activated both
proximal and distal WT reporter expression, but showed
no effects on mutant constructs in the absence of NOB.
These results suggested that the proximal C/EBP consen-
sus site plays a major role in mediating the NOB induction
of Cps1.Transcriptional regulation of other urea cycle genes by
NOB under HFD
A number of pioneering studies have provided strong
evidence for co-regulation of urea cycle genes by diets,
hormones, cAMP and other factors, likely as an evolu-
tionary strategy to efficiently perform ureagenesis in re-
sponse to various internal and external cues [8, 20, 35,
54–56]. In particular, C/EBP sites are found on several
urea cycle genes (Fig. 5a) [7, 8]. Under RC, NOB treat-
ment showed only modest effects on expression of the
four other urea cycle genes (Otc, Ass1, Asl, Arg1) relative
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Fig. 4 C/EBP binding site mutations in proximal and distal Cps1 enhancer regions impaired NOB-mediated reporter activation. a Diagram of distal
and proximal C/EBP sites on the Cps1 promoter region. b and c Hepa1-6 cells were transfected with reporter constructs containing wild-type (WT;
white bars) and C/EBP binding site mutated (black bars) enhancer regions, and treated with NOB at the indicated doses. Co-transfection of C/EBPα
expression construct was also carried out in parallel. Each value represented mean ± SEM of three replicates from a single assay. The results are
representative of at least three independent experiments. b and c show results from reporter constructs containing distal and proximal WT and
mutant enhancers respectively. Two-way ANOVA with Bonferroni post-hoc tests: significant main effects of plasmid construct, (b) F = 81.43, p < 0.001,
(c) F = 254.97, p < 0.0001; NOB concentration effect, (b) F = 47.39, p < 0.0001, (c) F = 42.01, p < 0.0001; and a significant interaction between constructs
and NOB concentration, (b) F = 23, p < 0.0001, (c) F = 24.37, p < 0.0001
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strong phase shifts (Fig. 5), NOB enhanced their ex-
pression and/or amplitude, and interestingly also cor-
rect circadian phases. Note that a putative C/EBP site
on the Ass1 promoter has not been reported, suggest-
ing a secondary effect by C/EBP or other transcrip-
tional mechanisms [35]. Since C/EBPs are master
regulators of overall hepatic metabolic circuits includ-
ing glucose and lipid metabolism, coordinate regula-
tion of urea cycle genes by C/EBPs may enable
metabolic cross-talk between nitrogen homeostasis
and energy metabolism [55, 57].
Circadian ClockΔ19/Δ19 mutant mice displayed attenuated
CPS1 and C/EBP levels
Consistent with previous studies [27, 50, 58], our data
thus far indicated that both Cps1 and Cebp genes are
subjected to circadian control and display rhythmic pat-
terns of expression. To directly examine whether the cir-
cadian clock plays an essential role in Cps1 regulation,
we employed ClockΔ19/Δ19 mutant mice (Clk) which ex-
press a dominant negative version of CLOCK proteins and
thus are severely impaired in circadian rhythms [59, 60].Compared with WT, CPS1, C/EBPα p30 and C/EBPβ pro-
tein levels were markedly reduced and became largely
arrhythmic in Clk under RC feeding and constant darkness
(DD) conditions (Fig. 6a and see also quantification in
Additional file 1: Figure S3). In comparison, p42 expression
and oscillation were maintained in Clk mice, yet interest-
ingly displayed a reversed circadian phase pattern (Fig. 6a
and Additional file 1: Figure S3B). These observations
illustrated gene- or isoform-specific circadian expres-
sion regulation. Furthermore, pronounced expression
changes in C/EBP subunits were observed in the mu-
tant mice, including both phase shifts and reduced
levels (p30 and C/EBPβ). Cps1 and Cebpa mRNA ex-
pression was also compromised in the mutant mice,
showing strongly reduced levels and dampened circadian
amplitude (Fig. 6b). In comparison, Cebpb mRNA expres-
sion exhibited a marked phase shift in the mutant com-
pared with WT (Fig. 6b, bottom), while maintaining a
normal amplitude. Whereas CPS1 levels were lower in
Clk than WT, neither HFD nor NOB in mutant mice con-
ferred significant changes (Fig. 6c; lower panel: quantifica-
tion). These results together indicated a critical role of a
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Fig. 5 NOB coordinately enhanced urea cycle gene expression. a Diagram of C/EBP sites on the genomic regions for urea cycle genes including
Otc, Ass1, Asl, and Arg1. b-e Liver samples were collected from the four diet/treatment groups of wild-type mice at the indicated circadian time
points. Total RNAs were purified for real-time RT-PCR analysis using primers for the four urea cycle genes, including Otc (b), Ass1 c, Asl d and Arg1
e. RC regular chow, HFD high-fat diet, Veh vehicle, NOB Nobiletin. Data are presented as mean ± SEM (n = 3). Two-way ANOVA with Bonferroni
post-hoc tests, RC.Veh vs. HFD.Veh, a p < 0.0001, b p < 0.01, c p < 0.05, d p < 0.01. Student’s t-test, HFD.Veh vs. HFD.NOB, *p < 0.05, **p < 0.01
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Finally, to further elucidate a modulatory role of NOB in
nitrogen homeostasis, we measured urea content in
serum and urine at both day- and night-time. In RC,
serum urea levels were mildly reduced in the NOB
group at both day- and night-time (ZT6 and 18) (Fig. 7a),
whereas the urine urea levels showed the opposite trend,
suggesting increased urine urea excretion by NOB
(Fig. 7b). In comparison, HFD feeding led to lower
serum urea levels than RC (Fig. 7a). More importantly,
HFD showed a reverse NOB response; specifically, NOB
increased serum urea and concomitantly reduced renal
urea excretion, particularly at ZT18 (Fig. 7b). Theseresults further illustrated a modulatory role of NOB in
nitrogen homeostasis.
Discussion
In the current study, we demonstrated a broad effect of
the natural flavonoid NOB in reducing serum ammonia
levels under varying diet conditions. NOB and other re-
lated polymethoxylated flavonoids are dietary compo-
nents generally showing favorable pharmacokinetic
profiles [61, 62], and mouse and human studies revealed
promising efficacy of NOB against the metabolic syn-
drome without significant toxicity [40, 44, 45, 63]. The
current work illustrated a novel function of NOB in




























































Fig. 6 NOB restored Cps1 and Cebp mRNA and protein levels in a clock-dependent manner. a Liver samples were collected at the indicated Circadian
Times (CT) from regular chow-fed WT and ClockΔ19/Δ19 mutant (Clk) mice (n = 3) in constant darkness (DD) when the circadian clock free runs devoid
of light cue. CT0 corresponds to the onset of subjective day. Western blotting was performed using total protein extracts from the liver samples with
the indicated antibodies. See Additional file 1: Figure S3 for quantitative analysis. b Real-time RT-PCR analysis of Cps1, Cebpa and Cebpb was carried out
using total RNAs extracted from the liver samples described in (a). Data are presented as mean ± SEM. Two-way ANOVA with Bonferroni post-hoc tests,
WT vs. Clk, Cps1, Cebpb p < 0.01; Cebpa p < 0.05. Student’s t-test, WT vs. Clk, Cps1: CT4, *p < 0.05; Cebpa: CT8, *p < 0.05; Cebpb: CT8, **p < 0.01. c Western
blot analysis of CPS1 protein levels in liver samples collected at ZT8 and ZT20 from WT and Clk mice subjected to the indicated diet and treatment.
RC regular chow, HFD high-fat diet, Veh vehicle, NOB Nobiletin. Two-way ANOVA with Bonferroni post-hoc tests, WT vs. individual Clk groups, *p < 0.05
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logical benefits associated with NOB and other natural
flavonoids [63, 64]. In light of these beneficial attributes,
it warrants further investigation whether NOB can be in-
corporated into dietary management for congenital and
injury-induced hyperammonemia.
Our study revealed broad ammonia-lowering activities
of NOB in mice fed with RC, HFD or HPD, ostensibly
utilizing distinct, diet-specific mechanisms. Whereas
transcriptional activation of CPS1 via C/EBP induction
seems to operate under HFD, NOB treatment inconjunction with RC and HPD feeding appeared not to
elicit significant CPS1 induction. Moreover, in contrast
to RC where NOB similarly reduced serum ammonia at
both ZT6 and ZT18, in HFD and HPD NOB more
strongly diminished the relative high ammonia levels in
respective diets (ZT6 for HFD and ZT18 for HPD). As a
result, NOB functions to reverse the exaggerated ammo-
nia variation between the active and inactive phases, es-
sentially normalizing circadian ammonia rhythm in HFD
and HPD to RC levels. Given the remarkably diverse cel-
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Fig. 7 Effects of NOB on urea production. a and b Serum (a) and urine (b) urea levels at ZT6 and ZT18 in WT mice treated with Veh or NOB
under RC (n = 7) or HFD (n = 4). Data are presented as mean ± SEM. Student’s t-test, Veh vs. NOB, *p <0.05; RC vs. HFD, †p <0.05, ††p <0.01
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nisms may underlie such mechanistic and functional
plasticity [63–67]. Besides transcriptional regulation
(C/EBP, glucocorticoid receptor, CREB and HNF3) and
the allosteric cofactor NAG [7, 17], recent mechanistic
studies have also underscored the importance of post-
translational modifications (PTMs) for CPS1 protein
activity [11–13, 47]. Other urea cycle genes may also
serve as the primary target; one such candidate is Otc,
especially given its functional connection with the cir-
cadian clock [19]. Finally, NOB may also attenuate
HPD-induced bacterial production of ammonia by
amino acid deamination and urea hydrolysis [4].
Our analysis revealed differential responses of serum
and urine urea levels to NOB treatment in HFD. Urea
represents the most predominant circulating nitrogen
reservoir, and blood urea nitrogen (BUN) level is known
to be regulated by multiple factors including protein in-
take, protein metabolism and renal function [1, 5]. HFD
contains lower protein content than RC (20 % vs. 29 %
in calories), and NOB acts to attenuate ammonia levels
by activating urea cycle gene expression. Thus, urea may
be salvaged to maintain nitrogen balance in the HFD.NOB
condition. For example, urine excretion rate/volume and
renal reabsorption of water/mineral/urea are tightly
coupled to regulate osmotic pressure, which may in turn
modulate serum and urine urea levels. However, a direct
role of NOB in renal function remains to be elucidated.
Amino acid levels in human blood have been shown
to exhibit robust circadian oscillation, concordant with
results from a yeast metabolic cycle resembling mamma-
lian circadian rhythm [68–70]. In parallel with fluctuat-
ing amino acid levels over the daily cycle, CPS1 and
several other urea cycle components exhibited circadian
mRNA and protein expression patterns [27]. However,
much conflictory evidence has also been reported with
regard to Cps1 circadian expression [26, 28, 29]. Our ex-
periments, using specific primers and antibodies, re-
vealed weak oscillation of Cps1 mRNA and protein.
Interestingly, NOB appeared to augment CPS1 protein
oscillation under RC, and also enhanced CPS1 levelsunder HFD in a circadian clock-dependent manner. One
possible mechanism of circadian regulation may depend
on C/EBPs as their expression is subjected to clock con-
trol [50], although other mechanisms likely exist [19]. Of
note, we observed distinct circadian changes of C/EBPα
p42 and p30 isoforms in ClockΔ19/Δ19 mutant mice rela-
tive to WT, suggesting a possible circadian regulation of
alternative translation. Currently, work in our lab aims
to further understand the detailed mechanism under-
lying the interaction between the clock, diet and NOB in
nitrogen homeostasis.
Conclusion
In this current study, we present physiological evidence
indicating that NOB exhibits a broad activity in ammo-
nia control in mice fed with varying diets. Molecular ex-
periments further revealed that NOB regulates urea
cycle function via C/EBP- and circadian clock-dependent
regulatory mechanisms. These observations together
demonstrate a novel physiological function and cellular
mechanism of a natural dietary flavonoid in nitrogen
homeostasis.
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S1B. Figure S1. NOB modulates CPS1 expression. (A) Quantification of
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NOB, Nobiletin. Two-way ANOVA with Bonferroni post-hoc tests shows
significant statistical differences between HFD.Veh and other three
groups (p < 0.0001). Furthermore, one-way ANOVA with Bonferroni tests
shows significant difference (p < 0.05) between ZT time points in
RC.Veh but not in other groups. (B) Coomassie blue staining of CPS1.
Mouse liver protein lysates were separated on SDS-PAGE gel and stained
with Coomassie blue. The predominant 164KD band was validated by mass
spectrometry as CPS1 (Table S3). (C) Control microscopy images for Fig. 2b
using rabbit IgG. Figure S2. NOB rescued C/EBP protein circadian
expression in the liver from HFD fed mice. (A) Quantification of C/EBPα
p42 protein levels from three independent experiments including the
blot shown in Fig. 3b. Two-way ANOVA with Bonferroni post-hoc tests
shows significant difference between RC.Veh and HFD.Veh (p < 0.05),
indicating diet effect on the C/EBPα p42 expression level. Importantly,
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reversed the reducing effect of HFD on the C/EBPα p42 expression. (B)
Quantification of C/EBPα p30 protein levels from three independent
experiments including the blot shown in Fig. 3b. Two-way ANOVA with
Bonferroni post-hoc tests shows significant difference between RC.Veh
and HFD.Veh (p < 0.01), but RC.NOB and HFD.NOB was not significantly
different, again suggesting NOB reversed the reducing effect of HFD on
the p30 expression. (C) Quantification of C/EBPβ protein levels from
three independent experiments including the blot shown in Fig. 3b.
Two-way ANOVA with Bonferroni post-hoc tests shows significant
difference between RC.Veh and HFD.Veh (p < 0.0001), but RC.NOB and
HFD.NOB was not significantly different. Figure S3. NOB restored CPS1
and C/EBP protein levels in a clock-dependent manner. (A) Quantification of
CPS1 protein levels under constant darkness (DD) conditions from three
independent experiments including the blot shown in Fig. 6a. Two-way
ANOVA with Bonferroni post-hoc tests shows significant statistical difference
between WT and Clk (ClockΔ19/Δ19) (p < 0.0001). (B) Quantification of C/EBPα
p42 protein levels under constant darkness (DD) conditions from three
independent experiments including the blot shown in Fig. 6a. Two-way
ANOVA with Bonferroni post-hoc tests shows significant statistical
differences between WT and Clk (p < 0.05). (C) Quantification of C/EBPα
p30 protein levels under constant darkness (DD) conditions from three
independent experiments including the blot shown in Fig. 6a. Two-way
ANOVA with Bonferroni post-hoc tests shows significant statistical
difference between WT and Clk (p < 0.01). (D) Quantification of C/EBPβ
protein levels under constant darkness (DD) conditions from three
independent experiments including the blot shown in Fig. 6a. Two-way
ANOVA with Bonferroni post-hoc tests shows significant statistical
difference between WT and Clk (p < 0.05).Abbreviations
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